3M
About: 3M, a multinational conglomerate founded in 1902, sells tens of thousands of products ranging from sponges to respirators. The firm is well known for its extensive research and development capabilities, and it is a pioneer in inventing new use cases for its proprietary technologies. 3M is organized across three business segments: safety and industrial (representing around 44% of revenue), transportation and electronics (36%), and consumer (20%). The firm recently spun off its healthcare business, now known as Solventum. Nearly half of 3M's revenue comes from outside the Americas.
Employees: 61,500
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
123% more call options, than puts
Call options by funds: $1.59B | Put options by funds: $710M
17% more first-time investments, than exits
New positions opened: 168 | Existing positions closed: 144
6% more capital invested
Capital invested by funds: $55.9B [Q1] → $59.5B (+$3.61B) [Q2]
2.21% more ownership
Funds ownership: 70.69% [Q1] → 72.9% (+2.21%) [Q2]
1% less funds holding
Funds holding: 2,121 [Q1] → 2,096 (-25) [Q2]
24% less funds holding in top 10
Funds holding in top 10: 33 [Q1] → 25 (-8) [Q2]
28% less repeat investments, than reductions
Existing positions increased: 640 | Existing positions reduced: 888
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
3 analyst ratings
Barclays Julian Mitchell | 11%upside $172 | Overweight Maintained | 21 Jul 2025 |
Wells Fargo Joe O'Dea | 9%upside $170 | Overweight Maintained | 1 Jul 2025 |
Citigroup Andrew Kaplowitz | 3%upside $160 | Neutral Maintained | 30 May 2025 |
Financial journalist opinion
Based on 16 articles about MMM published over the past 30 days
